More interesting is whether/when AMGN decides to launch and take a chance against ABBV's battery of US patents on Humira's formulation, manufacturing process, and method of use (#msg-118781959).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.